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Summary. The phenotypic variability of epithelial 
ovarian neoplasms correlates with a diversity of changes 
at the molecular level.  Invasive serous and un- 
differentiated ovarian carcinomas are characterized by 
p53 mutations with p53 protein accumulation, extensive 
loss of genetic material of chromosome 17 and complex 
changes on many other chromosomes, e.g. amplification 
of oncogenes. These alterations are seen only in a 
minority of mucinous and endometrioid carcinomas, 
mainly in advanced stages. Overexpression of bcl-2 is 
seen most frequently in endometrioid carcinomas (ca. 
90% of cases), which in addition show microsatellite 
instability in around a third of the cases, as has been 
described in endometrioid endometrial carcinomas. 
KRAS mutations are characteristic for mucinous LMP 
tumors and mucinous carcinomas (40-50% of cases) and 
are also found in a third of serous LMP tumors. In 
addition, serous LMP tumors show mild microsatellite 
instability in 30%. However, complex chromosomal 
aberrations are never seen in these neoplasms. 
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Introduction 
Epithelia1 ovarian neoplasms are thought to arise 
from the ovarian surface epithelium and its inclusion 
cysts. The different phenotypes of these tumors reflect 
the various differentiation patterns of the Mullerian 
epithelium of the female genital tract. The serous (tubal), 
mucinous (endocervical) and endometrioid type are the 
three types encountered most frequently. Most un- 
differentiated ovarian carcinomas probably represent 
dedifferentiated serous carcinomas (Russell, 1994). 
Epithelial ovarian neoplasms are further subclassified 
into benign, borderline and malignant tumors according 
to their degree of proliferation, cytological atypia and 
the presence or absence of stromal invasion. The 
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biological position of the non-invasive borderline 
tumors, also called tumors of low malignant potential 
(LMP), is still unclear. At present there is controversy as 
to whether LMP tumors represent a precursor lesion of 
invasive carcinomas or a distinct entity developing 
through a separate molecular pathway (Russell, 1994). 
The biological behavior of the various forms of 
epithelial ovarian tumors differs considerably. 5-year 
survival  rates of LMP tumors are above 90%.  
Comparable data for invasive carcinomas show a 
correlation to the histological type. In our own Munich 
study collective, treated between 1985 and 1992 5-year 
survival for endometrioid carcinoma was 67%, for 
mucinous carcinomas 62%, for serous carcinomas 34% 
and for undifferentiated carcinomas 23% (Diebold et al., 
1996a). However, it has to be taken into account that 
endometrioid and mucinous carcinomas are relatively 
often diagnosed in FIGO stage I, whereas most serous 
and undifferentiated carcinomas are advanced stage 
carcinomas at the time of surgery (FIGO I1 or 111) 
(Diebold et al, 1996a). 
Recent molecular  pathological s tudies  have 
improved our understanding of the molecular basis of 
ovarian carcinogenesis. It has been shown that the 
phenotypic differences between the various forms of 
epithelial ovarian neoplasia correlate with different 
changes at the molecular level (Pieretti et al., 1995; 
Diebold et al., 1996a,b, 1997b). This review summarizes 
the characteristic changes of the main types of epithelial 
ovarian tumors. The description focuses on invasive 
carcinomas and LMP tumors, because only few data are 
available for adenomas. Furthermore, only those studies 
which have taken the histological tumor type into 
account will be discussed. 
Invasive serous carcinomas 
Multiple tumor cytogenetic and molecular genetic 
alterations are found in advanced serous and un- 
differentiated ovarian carcinomas. These alterations are 
associated with gross changes of the nuclear amount of 
DNA, reflected by DNA non-diploidy in DNA cyto- 
metry (Table 1). Serous and undifferentiated tumors 
show the highest proliferative activity of all types of 
epithelial ovarian neoplasms (Table 1). 








